| 2026-01-05 |
详情>>
内部人交易：
Dube Michael P等共交易8笔
|
| 2025-11-06 |
详情>>
股本变动：
变动后总股本11582.99万股
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-2.99美元,归母净利润-3.17亿美元,同比去年增长18.77%
|
| 2025-10-27 |
复牌提示：
2025-10-27 07:25:00 停牌，复牌日期 2025-10-27 07:50:00
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益-2.08美元,归母净利润-2.16亿美元,同比去年增长15.26%
|
| 2025-08-07 |
财报披露：
美东时间 2025-08-07 盘前发布财报
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益-1.1美元,归母净利润-1.14亿美元,同比去年增长-6.42%
|
| 2025-04-30 |
股东大会：
将于2025-06-11召开股东大会
会议内容 ▼▲
- 1.Election of three class III directors to our board of directors, each to serve until the 2028 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal
2.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025
3.Approval, on a non-binding advisory basis, of the compensation of our named executive officers;
4.Non-binding advisory vote on the frequency of future non-binding advisory votes on the compensation of our named executive officers;
5.Approval of the Intellia Therapeutics, Inc. 2025 Equity Incentive Plan;
6.Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement thereof.
|
| 2025-02-27 |
详情>>
业绩披露：
2022年年报每股收益-6.16美元,归母净利润-4.74亿美元,同比去年增长-77.01%
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益-5.25美元,归母净利润-5.19亿美元,同比去年增长-7.86%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-3.99美元,归母净利润-3.9亿美元,同比去年增长-11.77%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益-2.64美元,归母净利润-2.54亿美元,同比去年增长-12.17%
|
| 2024-05-09 |
详情>>
业绩披露：
2024年一季报每股收益-1.12美元,归母净利润-1.07亿美元,同比去年增长-4.18%
|
| 2024-04-29 |
股东大会：
将于2024-06-12召开股东大会
会议内容 ▼▲
- 1.Election of two class II directors to our board of directors, each to serve until the 2027 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal
2.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024
3.Approval, on a non-binding advisory basis, of the compensation of our named executive officers;
4.Approval of a second amendment to our Second Amended and Restated Certificate of Incorporation, as amended, to limit the liability of certain officers of the Company as permitted by recent amendments to the Delaware General Corporation Law;
5.Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement thereof.
|
| 2024-02-22 |
详情>>
业绩披露：
2023年年报每股收益-5.42美元,归母净利润-4.81亿美元,同比去年增长-1.48%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-3.96美元,归母净利润-3.49亿美元,同比去年增长3.26%
|
| 2023-05-01 |
股东大会：
将于2023-06-14召开股东大会
会议内容 ▼▲
- 1.Election of three class I directors to our board of directors, each to serve until the 2026 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal;
2.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.Approval, on a non-binding advisory basis, of the compensation of our named executive officers;
4.Approval of an amendment to our Second Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 120,000,000 to 240,000,000;
5.Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement thereof.
|
| 2022-05-02 |
股东大会：
将于2022-06-14召开股东大会
会议内容 ▼▲
- 1.Election of three class III directors to our board of directors, each to serve until the 2025 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal;
2.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.Approval, on a non-binding advisory basis, of the compensation of our named executive officers;
4.Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-28 |
股东大会：
将于2021-06-23召开股东大会
会议内容 ▼▲
- 1.Election of three class II directors to our board of directors, each to serve until the 2024 annual meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal.
2.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021.
3.Approval, on a non-binding advisory basis, of the compensation of our named executive officers.
4.Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement thereof.
|
| 2020-04-24 |
股东大会：
将于2020-06-18召开股东大会
会议内容 ▼▲
- 1.Election of two class I directors to our board of directors, each to serve until the 2023 annual meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal
2.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020
3.Approval, on a non-binding advisory basis, of the compensation of our named executive officers;
4.Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement thereof.
|
| 2019-04-16 |
股东大会：
将于2019-05-21召开股东大会
会议内容 ▼▲
- 1.Election of three class III directors to our board of directors, to serve until the 2022 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal;
2.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019;
3.To consider and act upon an advisory vote on the compensation of our named executive officers;
4.To consider and act upon an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers;
5.Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement thereof.
|
| 2018-04-17 |
股东大会：
将于2018-05-17召开股东大会
会议内容 ▼▲
- 1.Election of one class II director to our board of directors, to serve until the 2021 annual meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier resignation or removal;
2.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018;
3.Transaction of any other business properly brought before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|